Coronet Ventures

Aevice Health specializes in non-invasive wearable technology designed for real-time monitoring of respiratory health. Their devices facilitate early detection of cardiopulmonary issues by recording relevant historical data regarding symptoms and medication intake, allowing clinicians to track patient responses to treatment effectively even when patients are at home. This approach enhances patient care by delivering critical insights remotely.

Engine Biosciences, established in 2014 and headquartered in Singapore, specializes in drug discovery and cellular reprogramming. The company's core offering is a validated platform that combines artificial intelligence and genetic perturbation to uncover gene interactions and biological networks. This platform enables researchers and drug developers to create targeted therapies and apply precision medicine. Engine Biosciences caters to prominent American corporations and research institutions, accelerating and reducing the costs of R&D for new medical therapies.